This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Hardware wallets generally offer stronger offline protection, while software wallets trade convenience for higher risk. This overview helps decide.
21,982 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
A rare look at how a mega-charity stewards billions in investments, the risk of concentration, and practical steps yo...
The Trade Desk slid again amid reports of agency cautions and analyst downgrades. This piece explains the drivers, wh...
Funding pressures on the U.S. Postal Service are intensifying policy debate about last-mile delivery. Private carrier...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Oil jumped sharply in March 2026, but USOI investors faced capped upside and ongoing credit risk. The piece explains ...
Timing matters for Required Minimum Distributions. Learn practical strategies to decide when to take your RMDs, how t...
A new flashpoint in the Strait of Hormuz triggers the fourth large supply shock this decade. Energy prices jump, infl...
When a trusted news anchor becomes a headline, families feel the impact firsthand. This article explores how grief sh...
Seven U.S. spot XRP ETFs have drawn $1.44B since late 2025, but XRP’s price remains volatile as inflows outpace gains.
The S&P 500 has slipped from its January peak, creating a dilemma for investors: chase a rebound or wait for more cla...